BlackRock’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.7K | Hold |
22,793
| – | – | ﹤0.01% | 4917 |
|
|
2025
Q1 | $27.4K | Hold |
22,793
| – | – | ﹤0.01% | 4990 |
|
|
2024
Q4 | $38.7K | Hold |
22,793
| – | – | ﹤0.01% | 4946 |
|
|
2024
Q3 | $53.6K | Hold |
22,793
| – | – | ﹤0.01% | 4750 |
|
|
2024
Q2 | $66.6K | Hold |
22,793
| – | – | ﹤0.01% | 4745 |
|
|
2024
Q1 | $69.3K | Hold |
22,793
| – | – | ﹤0.01% | 4749 |
|
|
2023
Q4 | $64.7K | Sell |
22,793
-1,266
| -5% | -$3.6K | ﹤0.01% | 4839 |
|
|
2023
Q3 | $65K | Hold |
24,059
| – | – | ﹤0.01% | 4883 |
|
|
2023
Q2 | $38.5K | Hold |
24,059
| – | – | ﹤0.01% | 5025 |
|
|
2023
Q1 | $53.9K | Sell |
24,059
-1
| -0% | -$2 | ﹤0.01% | 5017 |
|
|
2022
Q4 | $90.9K | Sell |
24,060
-28
| -0.1% | -$106 | ﹤0.01% | 4985 |
|
|
2022
Q3 | $89K | Sell |
24,088
-43
| -0.2% | -$159 | ﹤0.01% | 5119 |
|
|
2022
Q2 | $333K | Sell |
24,131
-3,164
| -12% | -$43.7K | ﹤0.01% | 4800 |
|
|
2022
Q1 | $589K | Sell |
27,295
-141
| -0.5% | -$3.04K | ﹤0.01% | 4744 |
|
|
2021
Q4 | $741K | Buy |
27,436
+2,488
| +10% | +$67.2K | ﹤0.01% | 4683 |
|
|
2021
Q3 | $1.44M | Buy |
24,948
+776
| +3% | +$44.7K | ﹤0.01% | 4388 |
|
|
2021
Q2 | $2.42M | Sell |
24,172
-55,247
| -70% | -$5.54M | ﹤0.01% | 4110 |
|
|
2021
Q1 | $12.1M | Buy |
79,419
+64,078
| +418% | +$9.74M | ﹤0.01% | 3408 |
|
|
2020
Q4 | $1.84M | Buy |
15,341
+463
| +3% | +$55.4K | ﹤0.01% | 3996 |
|
|
2020
Q3 | $3.54M | Buy |
14,878
+9,343
| +169% | +$2.22M | ﹤0.01% | 3628 |
|
|
2020
Q2 | $1.57M | Buy |
5,535
+5,379
| +3,448% | +$1.53M | ﹤0.01% | 3814 |
|
|
2020
Q1 | $47K | Buy |
156
+43
| +38% | +$13K | ﹤0.01% | 4409 |
|
|
2019
Q4 | $22K | Buy |
113
+23
| +26% | +$4.48K | ﹤0.01% | 4578 |
|
|
2019
Q3 | $22K | Sell |
90
-5
| -5% | -$1.22K | ﹤0.01% | 4582 |
|
|
2019
Q2 | $36K | Buy |
+95
| New | +$36K | ﹤0.01% | 4563 |
|